Predictors of substance use initiation by early adolescence / ReJoyce Green en The American Journal of Psychiatry, Año 2024 - Vol. 181 - No. 5 (Mayo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2024 - Vol. 181 - No. 5 (Mayo) . - pp. 423-433 Título : Predictors of substance use initiation by early adolescence Tipo de documento: texto impreso Autores: ReJoyce Green, Autor ; Bethany J. Wolf, Autor ; Andrew Chen, Autor Fecha de publicación: 2025 Artículo en la página: pp. 423-433 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Psiquiatría infantil y adolescente, Desarrollo, Trastornos adictivos y relacionados con sustancias. Resumen: Substance use initiation during early adolescence is associated with later development of substance use and mental health disorders. This study used various domains to predict substance use initiation, defined as trying any nonprescribed substance (e.g., alcohol, tobacco, cannabis), by age 12, using a large longitudinal data set. Link: ./index.php?lvl=notice_display&id=31507 [artículo] Predictors of substance use initiation by early adolescence [texto impreso] / ReJoyce Green, Autor ; Bethany J. Wolf, Autor ; Andrew Chen, Autor . - 2025 . - pp. 423-433. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2024 - Vol. 181 - No. 5 (Mayo) . - pp. 423-433 Palabras clave: Psiquiatría infantil y adolescente, Desarrollo, Trastornos adictivos y relacionados con sustancias. Resumen: Substance use initiation during early adolescence is associated with later development of substance use and mental health disorders. This study used various domains to predict substance use initiation, defined as trying any nonprescribed substance (e.g., alcohol, tobacco, cannabis), by age 12, using a large longitudinal data set. Link: ./index.php?lvl=notice_display&id=31507

Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction / Lara A. Ray en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.9 (Septiembre)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.9 (Septiembre) . - pp. 818-828 Título : Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction : a randomized clinical trial Tipo de documento: texto impreso Autores: Lara A. Ray, Autor ; ReJoyce Green, Autor ; Craig Enders, Autor Fecha de publicación: 2021 Artículo en la página: pp. 818-828 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Dejar de fumar, Consumo excesivo de alcohol, Vareniclina, Naltrexona, Ensayo clínico Resumen: Pharmacological treatments that can concomitantly address cigarette smoking and heavy drinking stand to improve health care delivery for these highly prevalent co-occurring conditions. This superiority trial compared the combination of varenicline and naltrexone against varenicline alone for smoking cessation and drinking reduction among heavy-drinking smokers. Link: ./index.php?lvl=notice_display&id=27333 [artículo] Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction : a randomized clinical trial [texto impreso] / Lara A. Ray, Autor ; ReJoyce Green, Autor ; Craig Enders, Autor . - 2021 . - pp. 818-828. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.9 (Septiembre) . - pp. 818-828 Palabras clave: Dejar de fumar, Consumo excesivo de alcohol, Vareniclina, Naltrexona, Ensayo clínico Resumen: Pharmacological treatments that can concomitantly address cigarette smoking and heavy drinking stand to improve health care delivery for these highly prevalent co-occurring conditions. This superiority trial compared the combination of varenicline and naltrexone against varenicline alone for smoking cessation and drinking reduction among heavy-drinking smokers. Link: ./index.php?lvl=notice_display&id=27333

---

1 (1 - 2 / 2)